Altrius Capital Management Inc Astrazeneca PLC Transaction History
Altrius Capital Management Inc
- $367 Million
- Q4 2024
A detailed history of Altrius Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Altrius Capital Management Inc holds 115,153 shares of AZN stock, worth $8.33 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
115,153
Previous 108,790
5.85%
Holding current value
$8.33 Million
Previous $8.48 Million
11.0%
% of portfolio
2.06%
Previous 2.17%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,339Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.55 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.04 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.7 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.66 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...